Noninvasive visualization of early osteoarthritic cartilage using targeted nanosomes in a destabilization of the medial meniscus mouse model

Hongsik Cho, Byoung Ju Kim, Sang Hyug Park, Karen Hasty, Byoung Hyun Min

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Early stage osteoarthritis (OA) is clinically asymptomatic due to the avascular and the aneural nature of the cartilage tissue. Nevertheless, early detection of cartilage tissue is critical in order to impede the progression of OA. Hence, in order to develop effective preventive therapy for OA, diagnosis in the early stages is necessary. Methods: To achieve this goal, we have developed targeted, fluorescent nanosomes conjugated with monoclonal anti-type II collagen antibodies (MabCII) for diagnosis of early OA. The MabCII-coated nanosomes (targeted-nanosomes) bind to the damaged cartilage explants in vitro and in vivo in an OA mouse model that mimics early stage OA. The OA mouse model was induced by destabilization of the medial meniscus (DMM) in 9-10 weeks old C57Bl/6 mice. Results: The targeted-nanosomes enhanced the binding specificity to the cartilage tissue according to the severity of damage. Conclusion: We show that MabCII-nanosomes can precisely detect early stage OA in the DMM mouse model. Thus, MabCII-nanosomes have the potential to be used as a non-invasive method for diagnosing the early osteoarthritic lesions.

Original languageEnglish (US)
Pages (from-to)1215-1224
Number of pages10
JournalInternational journal of nanomedicine
Volume13
DOIs
StatePublished - Mar 1 2018

Fingerprint

Tibial Meniscus
Cartilage
Osteoarthritis
Visualization
Tissue
Collagen Type II
Collagen
Antibodies

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Bioengineering
  • Biomaterials
  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry

Cite this

Noninvasive visualization of early osteoarthritic cartilage using targeted nanosomes in a destabilization of the medial meniscus mouse model. / Cho, Hongsik; Kim, Byoung Ju; Park, Sang Hyug; Hasty, Karen; Min, Byoung Hyun.

In: International journal of nanomedicine, Vol. 13, 01.03.2018, p. 1215-1224.

Research output: Contribution to journalArticle

@article{ccc80d68c22e49a1887de1c7ec24a360,
title = "Noninvasive visualization of early osteoarthritic cartilage using targeted nanosomes in a destabilization of the medial meniscus mouse model",
abstract = "Background: Early stage osteoarthritis (OA) is clinically asymptomatic due to the avascular and the aneural nature of the cartilage tissue. Nevertheless, early detection of cartilage tissue is critical in order to impede the progression of OA. Hence, in order to develop effective preventive therapy for OA, diagnosis in the early stages is necessary. Methods: To achieve this goal, we have developed targeted, fluorescent nanosomes conjugated with monoclonal anti-type II collagen antibodies (MabCII) for diagnosis of early OA. The MabCII-coated nanosomes (targeted-nanosomes) bind to the damaged cartilage explants in vitro and in vivo in an OA mouse model that mimics early stage OA. The OA mouse model was induced by destabilization of the medial meniscus (DMM) in 9-10 weeks old C57Bl/6 mice. Results: The targeted-nanosomes enhanced the binding specificity to the cartilage tissue according to the severity of damage. Conclusion: We show that MabCII-nanosomes can precisely detect early stage OA in the DMM mouse model. Thus, MabCII-nanosomes have the potential to be used as a non-invasive method for diagnosing the early osteoarthritic lesions.",
author = "Hongsik Cho and Kim, {Byoung Ju} and Park, {Sang Hyug} and Karen Hasty and Min, {Byoung Hyun}",
year = "2018",
month = "3",
day = "1",
doi = "10.2147/IJN.S149375",
language = "English (US)",
volume = "13",
pages = "1215--1224",
journal = "International Journal of Nanomedicine",
issn = "1176-9114",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Noninvasive visualization of early osteoarthritic cartilage using targeted nanosomes in a destabilization of the medial meniscus mouse model

AU - Cho, Hongsik

AU - Kim, Byoung Ju

AU - Park, Sang Hyug

AU - Hasty, Karen

AU - Min, Byoung Hyun

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Background: Early stage osteoarthritis (OA) is clinically asymptomatic due to the avascular and the aneural nature of the cartilage tissue. Nevertheless, early detection of cartilage tissue is critical in order to impede the progression of OA. Hence, in order to develop effective preventive therapy for OA, diagnosis in the early stages is necessary. Methods: To achieve this goal, we have developed targeted, fluorescent nanosomes conjugated with monoclonal anti-type II collagen antibodies (MabCII) for diagnosis of early OA. The MabCII-coated nanosomes (targeted-nanosomes) bind to the damaged cartilage explants in vitro and in vivo in an OA mouse model that mimics early stage OA. The OA mouse model was induced by destabilization of the medial meniscus (DMM) in 9-10 weeks old C57Bl/6 mice. Results: The targeted-nanosomes enhanced the binding specificity to the cartilage tissue according to the severity of damage. Conclusion: We show that MabCII-nanosomes can precisely detect early stage OA in the DMM mouse model. Thus, MabCII-nanosomes have the potential to be used as a non-invasive method for diagnosing the early osteoarthritic lesions.

AB - Background: Early stage osteoarthritis (OA) is clinically asymptomatic due to the avascular and the aneural nature of the cartilage tissue. Nevertheless, early detection of cartilage tissue is critical in order to impede the progression of OA. Hence, in order to develop effective preventive therapy for OA, diagnosis in the early stages is necessary. Methods: To achieve this goal, we have developed targeted, fluorescent nanosomes conjugated with monoclonal anti-type II collagen antibodies (MabCII) for diagnosis of early OA. The MabCII-coated nanosomes (targeted-nanosomes) bind to the damaged cartilage explants in vitro and in vivo in an OA mouse model that mimics early stage OA. The OA mouse model was induced by destabilization of the medial meniscus (DMM) in 9-10 weeks old C57Bl/6 mice. Results: The targeted-nanosomes enhanced the binding specificity to the cartilage tissue according to the severity of damage. Conclusion: We show that MabCII-nanosomes can precisely detect early stage OA in the DMM mouse model. Thus, MabCII-nanosomes have the potential to be used as a non-invasive method for diagnosing the early osteoarthritic lesions.

UR - http://www.scopus.com/inward/record.url?scp=85042756018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042756018&partnerID=8YFLogxK

U2 - 10.2147/IJN.S149375

DO - 10.2147/IJN.S149375

M3 - Article

C2 - 29535518

AN - SCOPUS:85042756018

VL - 13

SP - 1215

EP - 1224

JO - International Journal of Nanomedicine

JF - International Journal of Nanomedicine

SN - 1176-9114

ER -